IL124994A - Taxoids preparation thereof and pharmaceutical compositions containing same - Google Patents

Taxoids preparation thereof and pharmaceutical compositions containing same

Info

Publication number
IL124994A
IL124994A IL12499496A IL12499496A IL124994A IL 124994 A IL124994 A IL 124994A IL 12499496 A IL12499496 A IL 12499496A IL 12499496 A IL12499496 A IL 12499496A IL 124994 A IL124994 A IL 124994A
Authority
IL
Israel
Prior art keywords
taxoids
preparation
pharmaceutical compositions
compositions containing
containing same
Prior art date
Application number
IL12499496A
Other languages
English (en)
Other versions
IL124994A0 (en
Original Assignee
Rhone Poulenc Rorer Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Gmbh filed Critical Rhone Poulenc Rorer Gmbh
Publication of IL124994A0 publication Critical patent/IL124994A0/xx
Publication of IL124994A publication Critical patent/IL124994A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL12499496A 1995-12-22 1996-12-19 Taxoids preparation thereof and pharmaceutical compositions containing same IL124994A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515379A FR2742751B1 (fr) 1995-12-22 1995-12-22 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1996/002031 WO1997023473A1 (fr) 1995-12-22 1996-12-19 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
IL124994A0 IL124994A0 (en) 1999-01-26
IL124994A true IL124994A (en) 2000-12-06

Family

ID=9485871

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12499496A IL124994A (en) 1995-12-22 1996-12-19 Taxoids preparation thereof and pharmaceutical compositions containing same

Country Status (40)

Country Link
US (1) US5728849A (pm)
EP (1) EP0876362B1 (pm)
JP (1) JP3953106B2 (pm)
KR (1) KR100500351B1 (pm)
CN (1) CN1103766C (pm)
AR (1) AR005197A1 (pm)
AT (1) ATE250593T1 (pm)
AU (1) AU712597B2 (pm)
BG (1) BG63204B1 (pm)
BR (1) BR9612135A (pm)
CA (1) CA2238884C (pm)
CO (1) CO4520184A1 (pm)
CZ (1) CZ294972B6 (pm)
DE (1) DE69630145T2 (pm)
DK (1) DK0876362T3 (pm)
DZ (1) DZ2149A1 (pm)
EA (1) EA001533B1 (pm)
ES (1) ES2202490T3 (pm)
FR (1) FR2742751B1 (pm)
HU (1) HU225032B1 (pm)
IL (1) IL124994A (pm)
IN (4) IN186768B (pm)
MA (1) MA26412A1 (pm)
MX (1) MX9804688A (pm)
MY (1) MY113934A (pm)
NO (1) NO317358B1 (pm)
NZ (1) NZ324337A (pm)
OA (1) OA10700A (pm)
PE (1) PE25198A1 (pm)
PL (1) PL189311B1 (pm)
PT (1) PT876362E (pm)
RO (1) RO116194B1 (pm)
SK (1) SK282835B6 (pm)
TN (1) TNSN96169A1 (pm)
TR (1) TR199801179T2 (pm)
TW (1) TW371659B (pm)
UA (1) UA48205C2 (pm)
UY (1) UY24386A1 (pm)
WO (1) WO1997023473A1 (pm)
ZA (1) ZA9610737B (pm)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
SK13632001A3 (sk) 2000-02-02 2002-06-04 Florida State University Research Foundation, Inc. C10 karbonátom substituované taxány ako protinádorové činidlá
CA2435730C (en) * 2001-02-24 2011-03-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
EP1663153A4 (en) * 2003-05-20 2011-01-05 Aronex Pharmaceuticals Inc COMBINATION SCHEMOTHERAPY WITH A LIPOSOMAL PLATINUM COMPLEX
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1669358A1 (en) * 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
CN109503584A (zh) 2006-05-04 2019-03-22 勃林格殷格翰国际有限公司 多晶型
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
EP3542801A1 (en) * 2007-08-17 2019-09-25 Boehringer Ingelheim International GmbH Purin derivatives for use in the treatment of fap-related diseases
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
PE20110297A1 (es) * 2008-08-15 2011-05-26 Boehringer Ingelheim Int Inhibidores de dpp-4 para la cicatrizacion de heridas
KR20110067096A (ko) 2008-09-10 2011-06-21 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 및 관련 상태를 치료하기 위한 병용 요법
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EP2382216A1 (en) 2008-12-23 2011-11-02 Boehringer Ingelheim International GmbH Salt forms of organic compound
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
KR20120107080A (ko) 2009-11-27 2012-09-28 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
EA033415B1 (ru) 2010-05-05 2019-10-31 Boehringer Ingelheim Int Способы лечения ожирения, применение ингибитора dpp-4 в этих способах и способ лечения пациентов, страдающих диабетом типа 2
KR20130093012A (ko) 2010-06-24 2013-08-21 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
PL3517539T3 (pl) 2011-07-15 2023-04-24 Boehringer Ingelheim International Gmbh Podstawiona dimeryczna pochodna chinazoliny, sposób jej wytwarzania i jej zastosowanie w kompozycjach farmaceutycznych do leczenia cukrzycy typu I i II
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
EP2849754B1 (en) 2012-05-14 2022-09-14 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2014080251A1 (en) 2012-11-24 2014-05-30 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
FR3010839B1 (fr) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas Dispositif de raccordement electrique d'au moins un conducteur dans une borne appartenant a un appareil electrique
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
WO2015127685A1 (en) 2014-02-28 2015-09-03 Hangzhou Dac Biotech Co., Ltd Charged linkers and their uses for conjugation
WO2015151081A2 (en) 2015-07-12 2015-10-08 Suzhou M-Conj Biotech Co., Ltd Bridge linkers for conjugation of a cell-binding molecule
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
AU2017276758A1 (en) 2016-06-10 2018-11-08 Boehringer Ingelheim International Gmbh Combinations of Linagliptin and metformin
US12364767B2 (en) 2016-11-14 2025-07-22 Hangzhou Dac Biotech Co., Ltd. Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers
JP2024541058A (ja) 2021-11-03 2024-11-06 ハンジョウ ディーエーシー バイオテック シーオー.,エルティディ. 抗体の特異的共役

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
ES2134847T3 (es) * 1992-04-17 1999-10-16 Abbott Lab Derivados de taxol.
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
MX9307777A (es) * 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.

Also Published As

Publication number Publication date
CN1205697A (zh) 1999-01-20
DE69630145D1 (de) 2003-10-30
AU1180997A (en) 1997-07-17
CO4520184A1 (es) 1997-10-15
FR2742751A1 (fr) 1997-06-27
OA10700A (fr) 2002-11-27
WO1997023473A1 (fr) 1997-07-03
PL327405A1 (en) 1998-12-07
PE25198A1 (es) 1998-05-10
RO116194B1 (ro) 2000-11-30
ATE250593T1 (de) 2003-10-15
HU225032B1 (en) 2006-05-29
EP0876362A1 (fr) 1998-11-11
HK1017895A1 (en) 1999-12-03
DE69630145T2 (de) 2004-07-15
TR199801179T2 (xx) 1998-10-21
BR9612135A (pt) 1999-07-13
TNSN96169A1 (fr) 2005-03-15
ES2202490T3 (es) 2004-04-01
KR19990076680A (ko) 1999-10-15
DZ2149A1 (fr) 2002-10-23
EA199800588A1 (ru) 1998-12-24
BG102569A (en) 1999-04-30
MA26412A1 (fr) 2004-12-20
ZA9610737B (en) 1997-06-27
AR005197A1 (es) 1999-04-14
UY24386A1 (es) 2001-08-27
US5728849A (en) 1998-03-17
CZ196198A3 (cs) 1998-09-16
NO982580L (no) 1998-06-05
IL124994A0 (en) 1999-01-26
EA001533B1 (ru) 2001-04-23
JP2000502671A (ja) 2000-03-07
JP3953106B2 (ja) 2007-08-08
MY113934A (en) 2002-06-29
MX9804688A (es) 1998-10-31
TW371659B (en) 1999-10-11
CZ294972B6 (cs) 2005-04-13
KR100500351B1 (ko) 2005-12-21
UA48205C2 (uk) 2002-08-15
SK85398A3 (en) 1998-11-04
PT876362E (pt) 2004-02-27
NO982580D0 (no) 1998-06-05
FR2742751B1 (fr) 1998-01-30
IN188680B (pm) 2002-10-26
CA2238884A1 (fr) 1997-07-03
HUP9904046A3 (en) 2001-08-28
DK0876362T3 (da) 2004-02-02
HUP9904046A1 (hu) 2001-04-28
PL189311B1 (pl) 2005-07-29
BG63204B1 (bg) 2001-06-29
IN186768B (pm) 2001-11-03
CN1103766C (zh) 2003-03-26
NZ324337A (en) 2000-03-27
EP0876362B1 (fr) 2003-09-24
CA2238884C (fr) 2007-02-06
IN188469B (pm) 2002-09-28
SK282835B6 (sk) 2002-12-03
AU712597B2 (en) 1999-11-11
IN188470B (pm) 2002-09-28
NO317358B1 (no) 2004-10-18

Similar Documents

Publication Publication Date Title
IL124994A0 (en) Taxoids preparation thereof and pharmaceutical compositions containing same
AP9701090A0 (en) Novel taxoids preparation thereof and pharmaceutical compositions containing same
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
IL122618A0 (en) Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them
IL117349A0 (en) N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
IL122717A0 (en) Compounds and pharmaceutical compositions containing them
IL119559A0 (en) Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL117878A (en) Taxoids their preparation and pharmaceutical compositions containing them
IL117815A0 (en) Ascomycins their preparation and pharmaceutical compositions containing them
IL125998A0 (en) Taxoids preparation thereof and pharmaceutical compositions containing them
AP9701094A0 (en) Novel taxoids preparation thereof and pharmaceutical compositions containing same
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
IL118672A0 (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
HUP9801751A3 (en) Benzopyrans their preparation and use and pharmaceutical compositions containing them
HU9603388D0 (en) New taxoids, preparation thereof and pharmaceutical compositions containing them
IL113415A (en) Dihydrodibenziso-quinolinediones their preparation and pharmaceutical compositions containing them
IL124415A (en) N, n'-bridged bisindolylmaleimides, their preparation and pharmaceutical compositions containing them
ZA9610740B (en) Taxoids their preparation and pharmaceutical compositions containing them
ZA962400B (en) Taxoids their preparation and pharmaceutical compositions containing them
IL123000A (en) Aza-anthracylinone derivatives their preparation and pharmaceutical compositions containing them
SI0817779T1 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
SI0821680T1 (en) Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
SI0817780T1 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees